Sartorius

Отрасль

Оборудование для биопроизводства, Промышленная химия

Темы

Платформы синтетической биологии и биопроизводство

Роль

Производитель — “…rug discovery to commercial manufacturing. Key points: - Mission: Simplify progress in the bio-century by tran…”

Почему это биоэкономика

Sartorius — крупный международный поставщик биореакторов, ферментационного оборудования и решений для биопроцессов.

Продукты: Octet® R2 BLI System; Octet® R4 BLI System; Octet® R8 BLI System; Octet® R8e BLI System - NEW; Octet® RH16 BLI System; Octet® RH96 BLI System; Octet® N1 BLI System; Octet® AS BLI System; Octet® BLI GxP Compliance Tools; Octet® BLI Biosensors & Kits

Применение

Biopharmaceutical labs · Chemical labs · Food labs · Academic labs · Life Science Research · Basic Research

Производственные площадки

Göttingen, Germany — Sartorius AG · Aubagne, France — Sartorius Stedim Biotech S.A.

Продукты (сайт)

Octet® R2 BLI System · Octet® R4 BLI System · Octet® R8 BLI System · Octet® R8e BLI System - NEW · Octet® RH16 BLI System · Octet® RH96 BLI System · Octet® N1 BLI System · Octet® AS BLI System · Octet® BLI GxP Compliance Tools · Octet® BLI Biosensors & Kits · Octet® BLI Automation & Integration · Incucyte® CX3 System

Прочитано на сайте компании: about · products · production · quality · rnd · leadership · contact · sustainability

Дочерние компании: Sartorius Stedim Biotech S.A. (71.5% stake) · Sartorius Lab Holding GmbH (100% stake)

• 2026-06 Последний статус: В первом полугодии 2026 г. компания выкупила оставшиеся 24 % дочерней Sartorius CellGenix GmbH. ↗ ↗ ↗
• 2026-05-21 Sartorius opens new competence center for cell and gene therapy components in Freiburg, Germany
  Sartorius is expanding its commitment to cell and gene therapy by opening a new, sustainable competence center in Freiburg, Germany, investing over €140 million to boost GMP-compliant production of quality-critical materials (cytokines, growth factors, media) …
• 2026-05-21 Sartorius eröffnet neues Kompetenzzentrum für Zell- und Gentherapie ‑Komponenten in Freiburg
  Sartorius eröffnet in Freiburg ein neues Kompetenzzentrum für die Entwicklung und Produktion qualitätskritischer Materialien für Zell- und Gentherapien, investiert über 140 Mio. Euro und verdoppelt die Kapazitäten. Das 18.000 m² große Facility, das vollständig …
• 2026-09-16 Sartorius and NIBRT announce partnership: Pioneering dedicated training center for intensified and continuous bioprocessing
  Sartorius is expanding its leadership in bioprocessing by partnering with NIBRT to create a premier training center in Dublin for intensified and fully continuous manufacturing, featuring its end-to-end Pionic platform to train thousands of scientists and …
• 2026-07-23 Sartorius setzt positive Dynamik fort und wächst weiter profitabel
  Sartorius continues a positive trajectory in H1 2026 with robust, currency-adjusted growth of 7.7% in operative revenue, supported by recurring consumables, and an improved EBITDA margin of 30.3%; the company confirms its full-year 2026 guidance, expecting …
• 2026-05-21 Sartorius Stedim Biotech opens new competence center for cell and gene therapy components in Freiburg, Germany
  Sartorius Stedim Biotech is expanding in Freiburg with a new 18,000 m² competence center for cell and gene therapy components, investing over €140 million to boost production of cytokines, growth factors, and related materials, while emphasizing sustainability …
• 2026-10-04 Sartorius stock reports 7.7 percent H1 sales growth
  Sartorius posted 7.7% organic H1 2026 sales growth with a 30.3% underlying EBITDA margin, signaling solid execution and a favorable margin framework ahead of the Q3 results. The company maintains guidance for 2026 (5–9% sales growth in constant currencies and …

Владельцы и инвесторы 4

Партнёры и сделки 1

Похожие компании

Applikon Biotechnology · Bioengineering AG · BIONET · TECNIC Bioprocess Solutions · Bilfinger Life Science · bbi-biotech GmbH · Kbiotech GmbH · CerCell A/S